NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes

Completed · Phase 4

Conditions studied: Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

In brief

This trial is conducted in the United States of America (USA). The aim of this trial is to assess control of blood sugar, safety, and patient acceptance of insulin aspart compared to insulin lispro, both in insulin pumps, in standard clinical practice.

Key facts

Study ID

NCT00095446

Run by

Novo Nordisk A/S

People needed

513

Starts

2004-07-01

Expected to finish

2005-03-01

Last updated by the study team

2017-01-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• People with Type I or Type II Diabetes
• 18 Years or Older.

Where it is running

• Novo Nordisk Investigational Site — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.